Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.9 USD | -2.31% | -2.60% | +15.40% |
May. 21 | UBS Adjusts Price Target on Ecolab to $270 From $269, Maintains Buy Rating | MT |
May. 16 | Everlasting momentum |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 35.51 and 31.69 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.58 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.40% | 66.91B | A- | ||
+0.88% | 50B | A- | ||
+21.10% | 42.94B | B+ | ||
+27.82% | 27.25B | A- | ||
+9.54% | 19.34B | C+ | ||
-2.65% | 16.7B | B+ | ||
+7.54% | 16.1B | B+ | ||
-25.63% | 15.65B | A- | ||
-11.57% | 15B | C+ | ||
-17.62% | 14.12B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ECL Stock
- Ratings Ecolab Inc.